     Proposed Nasdaq Global Market symbol  THOR   The number of shares of our common stock to be outstanding after this offering is based on 18,317,592 shares of common stock outstanding as of September30, 2018, including 654,771 shares of common stock subject to repurchase, after giving effect to the conversion of our outstanding shares of convertible preferred stock (including 11,365,348 shares of Series C convertible preferred stock issued on November 1, 2018) into 16,687,477 shares of common stock, and excludes:         2,156,607 shares of common stock issuable upon the exercise of outstanding stock options as of September30, 2018, at a weighted-average exercise price of $0.81 per share;         5,828,865 shares of common stock reserved for future issuance under our 2018 equity incentive plan, or the 2018 Plan (which number includes the 1,673,103 shares subject to stock options that have been approved to be granted upon the effective date of the 2018 Plan), as well as any automatic increases in the number of shares of our common stock reserved for future issuance under this plan, which will become effective upon the execution and delivery of the underwriting agreement for this offering (including shares of common stock reserved for issuance under our 2014 equity incentive plan, as amended, or the Prior Plan, which shares will be added to the shares reserved under the 2018 Plan upon its effectiveness); and         645,000 shares of common stock reserved for future issuance under our 2018 employee stock purchase plan, or the ESPP, as well as any automatic increases in the number of shares of our common stock reserved for future issuance under this plan, which will become effective upon the execution and delivery of the underwriting agreement for this offering.

  The number of shares of our common stock outstanding in the table above excludes, as of September30, 2018:         2,156,607 shares of common stock issuable upon the exercise of outstanding options as of September30, 2018, at a weighted-average exercise price of $0.81 per share;         5,828,865 shares of common stock reserved for future issuance under the 2018 Plan (which number includes the 1,673,103shares subject to stock options that have been approved to be granted upon the effective date of the 2018 Plan), as well as any automatic increases in the number of shares of our common stock reserved for future issuance under this plan, which will become effective upon the execution and delivery of the underwriting agreement for this offering (including shares of common stock reserved for issuance under our Prior Plan, which shares will be added to the shares reserved under the 2018 Plan upon its effectiveness); and         645,000 shares of common stock reserved for issuance under the ESPP, as well as any automatic increases in the number of shares of our common stock reserved for future issuance under this plan, which will become effective upon the execution and delivery of the underwriting agreement for this offering.

  The foregoing tables and calculations exclude:         2,156,607 shares of common stock issuable upon the exercise of outstanding options as of September30, 2018, at a weighted-average exercise price of $0.81 per share;         5,828,865shares of common stock reserved for future issuance under the 2018 Plan (which number includes the 1,673,103shares subject to stock options that have been approved to be granted upon the effective date of the 2018 Plan), as well as any automatic increases in the number of shares of our common stock reserved for future issuance under this plan, which will become effective upon the execution and delivery of the underwriting agreement for this offering (including shares of common stock reserved for issuance under our Prior Plan which shares will be added to the shares reserved under the 2018 Plan upon its effectiveness); and    69        Table of Contents           645,000 shares of common stock reserved for issuance under the ESPP, as well as any automatic increases in the number of shares of our common stock reserved for future issuance under this plan, which will become effective upon the execution and delivery of the underwriting agreement for this offering.

  (6) From January1, 2015 through October 31, 2018, we granted stock options to purchase an aggregate of 3,608,398 shares of our common stock at a weighted-average exercise price of $1.11 per share, to certain of our employees, consultants and directors in connection with services provided to us by such persons.

